Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:polymyxin b-containing product in otic dose form'
(id=14103610 ; fe=en:polymyxin b-containing product in otic dose form ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=931 creation date=2019-12-18 touchdate=2024-09-16 08:56:38.000)
≈ 41 relations sortantes

  1. en:polymyxin b-containing product in otic dose form -- r_associated #0: 40 / 1 -> en:chloroxylenol-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:chloroxylenol-containing product in otic dose form | rel=r_associated | relid=0 | w=40
  2. en:polymyxin b-containing product in otic dose form -- r_associated #0: 40 / 1 -> en:otic dosage form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:otic dosage form | rel=r_associated | relid=0 | w=40
  3. en:polymyxin b-containing product in otic dose form -- r_associated #0: 39 / 0.975 -> en:carbamide peroxide-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:carbamide peroxide-containing product in otic dose form | rel=r_associated | relid=0 | w=39
  4. en:polymyxin b-containing product in otic dose form -- r_associated #0: 38 / 0.95 -> en:polymyxin b-containing product in vaginal dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:polymyxin b-containing product in vaginal dose form | rel=r_associated | relid=0 | w=38
  5. en:polymyxin b-containing product in otic dose form -- r_associated #0: 36 / 0.9 -> en:chloramphenicol-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:chloramphenicol-containing product in otic dose form | rel=r_associated | relid=0 | w=36
  6. en:polymyxin b-containing product in otic dose form -- r_associated #0: 35 / 0.875 -> en:desonide-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:desonide-containing product in otic dose form | rel=r_associated | relid=0 | w=35
  7. en:polymyxin b-containing product in otic dose form -- r_associated #0: 35 / 0.875 -> en:docusate-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:docusate-containing product in otic dose form | rel=r_associated | relid=0 | w=35
  8. en:polymyxin b-containing product in otic dose form -- r_associated #0: 35 / 0.875 -> en:glacial acetic acid-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:glacial acetic acid-containing product in otic dose form | rel=r_associated | relid=0 | w=35
  9. en:polymyxin b-containing product in otic dose form -- r_associated #0: 35 / 0.875 -> en:pramoxine-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:pramoxine-containing product in otic dose form | rel=r_associated | relid=0 | w=35
  10. en:polymyxin b-containing product in otic dose form -- r_associated #0: 34 / 0.85 -> en:bacitracin-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:bacitracin-containing product in otic dose form | rel=r_associated | relid=0 | w=34
  11. en:polymyxin b-containing product in otic dose form -- r_associated #0: 34 / 0.85 -> en:ofloxacin-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:ofloxacin-containing product in otic dose form | rel=r_associated | relid=0 | w=34
  12. en:polymyxin b-containing product in otic dose form -- r_associated #0: 34 / 0.85 -> en:polymyxin b- and trimethoprim-containing product
    n1=en:polymyxin b-containing product in otic dose form | n2=en:polymyxin b- and trimethoprim-containing product | rel=r_associated | relid=0 | w=34
  13. en:polymyxin b-containing product in otic dose form -- r_associated #0: 32 / 0.8 -> en:bacitracin, polymyxin b drug combination
    n1=en:polymyxin b-containing product in otic dose form | n2=en:bacitracin, polymyxin b drug combination | rel=r_associated | relid=0 | w=32
  14. en:polymyxin b-containing product in otic dose form -- r_associated #0: 32 / 0.8 -> en:benzocaine-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:benzocaine-containing product in otic dose form | rel=r_associated | relid=0 | w=32
  15. en:polymyxin b-containing product in otic dose form -- r_associated #0: 32 / 0.8 -> en:betamethasone sodium phosphate 1 mg/ml ear or eye or nose drops
    n1=en:polymyxin b-containing product in otic dose form | n2=en:betamethasone sodium phosphate 1 mg/ml ear or eye or nose drops | rel=r_associated | relid=0 | w=32
  16. en:polymyxin b-containing product in otic dose form -- r_associated #0: 31 / 0.775 -> en:ciprofloxacin-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:ciprofloxacin-containing product in otic dose form | rel=r_associated | relid=0 | w=31
  17. en:polymyxin b-containing product in otic dose form -- r_associated #0: 31 / 0.775 -> en:colistin-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:colistin-containing product in otic dose form | rel=r_associated | relid=0 | w=31
  18. en:polymyxin b-containing product in otic dose form -- r_associated #0: 31 / 0.775 -> en:gentamicin-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:gentamicin-containing product in otic dose form | rel=r_associated | relid=0 | w=31
  19. en:polymyxin b-containing product in otic dose form -- r_associated #0: 31 / 0.775 -> en:hydrocortisone-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:hydrocortisone-containing product in otic dose form | rel=r_associated | relid=0 | w=31
  20. en:polymyxin b-containing product in otic dose form -- r_associated #0: 31 / 0.775 -> en:triethanolamine-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:triethanolamine-containing product in otic dose form | rel=r_associated | relid=0 | w=31
  21. en:polymyxin b-containing product in otic dose form -- r_associated #0: 30 / 0.75 -> en:aluminum-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:aluminum-containing product in otic dose form | rel=r_associated | relid=0 | w=30
  22. en:polymyxin b-containing product in otic dose form -- r_associated #0: 30 / 0.75 -> en:dexamethasone-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:dexamethasone-containing product in otic dose form | rel=r_associated | relid=0 | w=30
  23. en:polymyxin b-containing product in otic dose form -- r_associated #0: 30 / 0.75 -> en:otic form polymyxin b
    n1=en:polymyxin b-containing product in otic dose form | n2=en:otic form polymyxin b | rel=r_associated | relid=0 | w=30
  24. en:polymyxin b-containing product in otic dose form -- r_associated #0: 30 / 0.75 -> en:polymyxin b-containing product in parenteral dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:polymyxin b-containing product in parenteral dose form | rel=r_associated | relid=0 | w=30
  25. en:polymyxin b-containing product in otic dose form -- r_associated #0: 29 / 0.725 -> en:boric acid-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:boric acid-containing product in otic dose form | rel=r_associated | relid=0 | w=29
  26. en:polymyxin b-containing product in otic dose form -- r_associated #0: 29 / 0.725 -> en:choline salicylate-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:choline salicylate-containing product in otic dose form | rel=r_associated | relid=0 | w=29
  27. en:polymyxin b-containing product in otic dose form -- r_associated #0: 29 / 0.725 -> en:clioquinol-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:clioquinol-containing product in otic dose form | rel=r_associated | relid=0 | w=29
  28. en:polymyxin b-containing product in otic dose form -- r_associated #0: 29 / 0.725 -> en:polymyxin b-containing product in ocular dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:polymyxin b-containing product in ocular dose form | rel=r_associated | relid=0 | w=29
  29. en:polymyxin b-containing product in otic dose form -- r_associated #0: 28 / 0.7 -> en:acetic acid-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:acetic acid-containing product in otic dose form | rel=r_associated | relid=0 | w=28
  30. en:polymyxin b-containing product in otic dose form -- r_associated #0: 28 / 0.7 -> en:neomycin-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:neomycin-containing product in otic dose form | rel=r_associated | relid=0 | w=28
  31. en:polymyxin b-containing product in otic dose form -- r_associated #0: 28 / 0.7 -> en:polymyxin b in otic dosage form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:polymyxin b in otic dosage form | rel=r_associated | relid=0 | w=28
  32. en:polymyxin b-containing product in otic dose form -- r_associated #0: 28 / 0.7 -> en:polymyxin b only product
    n1=en:polymyxin b-containing product in otic dose form | n2=en:polymyxin b only product | rel=r_associated | relid=0 | w=28
  33. en:polymyxin b-containing product in otic dose form -- r_associated #0: 28 / 0.7 -> en:polymyxin b-containing product in cutaneous dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:polymyxin b-containing product in cutaneous dose form | rel=r_associated | relid=0 | w=28
  34. en:polymyxin b-containing product in otic dose form -- r_associated #0: 28 / 0.7 -> en:prednisolone sodium phosphate 5 mg/ml ear or eye drops solution
    n1=en:polymyxin b-containing product in otic dose form | n2=en:prednisolone sodium phosphate 5 mg/ml ear or eye drops solution | rel=r_associated | relid=0 | w=28
  35. en:polymyxin b-containing product in otic dose form -- r_associated #0: 27 / 0.675 -> en:neomycin- and polymyxin b-containing product
    n1=en:polymyxin b-containing product in otic dose form | n2=en:neomycin- and polymyxin b-containing product | rel=r_associated | relid=0 | w=27
  36. en:polymyxin b-containing product in otic dose form -- r_associated #0: 27 / 0.675 -> en:phenylephrine-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:phenylephrine-containing product in otic dose form | rel=r_associated | relid=0 | w=27
  37. en:polymyxin b-containing product in otic dose form -- r_associated #0: 27 / 0.675 -> en:polymyxin b
    n1=en:polymyxin b-containing product in otic dose form | n2=en:polymyxin b | rel=r_associated | relid=0 | w=27
  38. en:polymyxin b-containing product in otic dose form -- r_associated #0: 27 / 0.675 -> en:polymyxin b sulfate
    n1=en:polymyxin b-containing product in otic dose form | n2=en:polymyxin b sulfate | rel=r_associated | relid=0 | w=27
  39. en:polymyxin b-containing product in otic dose form -- r_associated #0: 27 / 0.675 -> en:triamcinolone-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:triamcinolone-containing product in otic dose form | rel=r_associated | relid=0 | w=27
  40. en:polymyxin b-containing product in otic dose form -- r_associated #0: 26 / 0.65 -> en:glycerin-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:glycerin-containing product in otic dose form | rel=r_associated | relid=0 | w=26
  41. en:polymyxin b-containing product in otic dose form -- r_associated #0: 26 / 0.65 -> en:sodium bicarbonate-containing product in otic dose form
    n1=en:polymyxin b-containing product in otic dose form | n2=en:sodium bicarbonate-containing product in otic dose form | rel=r_associated | relid=0 | w=26
≈ 41 relations entrantes

  1. en:desonide-containing product in otic dose form --- r_associated #0: 39 --> en:polymyxin b-containing product in otic dose form
    n1=en:desonide-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=39
  2. en:ciprofloxacin-containing product in otic dose form --- r_associated #0: 34 --> en:polymyxin b-containing product in otic dose form
    n1=en:ciprofloxacin-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=34
  3. en:sodium bicarbonate-containing product in otic dose form --- r_associated #0: 32 --> en:polymyxin b-containing product in otic dose form
    n1=en:sodium bicarbonate-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=32
  4. en:otic form polymyxin b --- r_associated #0: 31 --> en:polymyxin b-containing product in otic dose form
    n1=en:otic form polymyxin b | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=31
  5. en:polymyxin b in otic dosage form --- r_associated #0: 31 --> en:polymyxin b-containing product in otic dose form
    n1=en:polymyxin b in otic dosage form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=31
  6. en:ofloxacin-containing product in otic dose form --- r_associated #0: 28 --> en:polymyxin b-containing product in otic dose form
    n1=en:ofloxacin-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=28
  7. en:triamcinolone-containing product in otic dose form --- r_associated #0: 26 --> en:polymyxin b-containing product in otic dose form
    n1=en:triamcinolone-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=26
  8. en:acetic acid-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:acetic acid-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  9. en:aluminum-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:aluminum-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  10. en:bacitracin, polymyxin b drug combination --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:bacitracin, polymyxin b drug combination | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  11. en:bacitracin-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:bacitracin-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  12. en:benzocaine-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:benzocaine-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  13. en:betamethasone sodium phosphate 1 mg/ml ear or eye or nose drops --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:betamethasone sodium phosphate 1 mg/ml ear or eye or nose drops | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  14. en:boric acid-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:boric acid-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  15. en:carbamide peroxide-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:carbamide peroxide-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  16. en:chloramphenicol-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:chloramphenicol-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  17. en:chloroxylenol-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:chloroxylenol-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  18. en:choline salicylate-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:choline salicylate-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  19. en:clioquinol-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:clioquinol-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  20. en:colistin-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:colistin-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  21. en:dexamethasone-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:dexamethasone-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  22. en:docusate-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:docusate-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  23. en:gentamicin-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:gentamicin-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  24. en:glacial acetic acid-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:glacial acetic acid-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  25. en:glycerin-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:glycerin-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  26. en:hydrocortisone-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:hydrocortisone-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  27. en:neomycin- and polymyxin b-containing product --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:neomycin- and polymyxin b-containing product | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  28. en:neomycin-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:neomycin-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  29. en:otic dosage form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:otic dosage form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  30. en:phenylephrine-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:phenylephrine-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  31. en:polymyxin b --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:polymyxin b | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  32. en:polymyxin b only product --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:polymyxin b only product | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  33. en:polymyxin b sulfate --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:polymyxin b sulfate | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  34. en:polymyxin b- and trimethoprim-containing product --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:polymyxin b- and trimethoprim-containing product | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  35. en:polymyxin b-containing product in cutaneous dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:polymyxin b-containing product in cutaneous dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  36. en:polymyxin b-containing product in ocular dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:polymyxin b-containing product in ocular dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  37. en:polymyxin b-containing product in parenteral dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:polymyxin b-containing product in parenteral dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  38. en:polymyxin b-containing product in vaginal dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:polymyxin b-containing product in vaginal dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  39. en:pramoxine-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:pramoxine-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  40. en:prednisolone sodium phosphate 5 mg/ml ear or eye drops solution --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:prednisolone sodium phosphate 5 mg/ml ear or eye drops solution | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
  41. en:triethanolamine-containing product in otic dose form --- r_associated #0: 20 --> en:polymyxin b-containing product in otic dose form
    n1=en:triethanolamine-containing product in otic dose form | n2=en:polymyxin b-containing product in otic dose form | rel=r_associated | relid=0 | w=20
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr